Co-occurring genomic alterations and immunotherapy efficacy in NSCLC

by Fan Zhang, Jinliang Wang, Yu Xu, Shangli Cai, Tao Li, Guoqiang Wang, Chengcheng Li, Lei Zhao, Yi Hu
Published 2022-01-01

Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

by Puyuan Xing, Fan Zhang, Guoqiang Wang, Yu Xu, Chengcheng Li, Shouzheng Wang, Yiying Guo, Shangli Cai, Yan Wang, Junling Li
Published 2019-12-01

EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma

by Jie Wang, Zhijie Wang, Jianchun Duan, Rui Wan, Jiachen Xu, Kailun Fei, Chengcheng Li, Wenzhuan Xie, Zhengyi Zhao, Shangli Cai
Published 2020-07-01

Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer

by Zhiyu Wang, Zhuoqi Zhang, Ke Zhang, Qiaoxia Zhou, Sidong Chen, Hao Zheng, Guoqiang Wang, Shangli Cai, Fujing Wang, Shenglong Li
Published 2022-05-01

DNA Damage Response Gene-Based Subtypes Associated With Clinical Outcomes in Early-Stage Lung Adenocarcinoma

by Yang Zhao, Bei Qing, Chunwei Xu, Jing Zhao, Yuchen Liao, Peng Cui, Guoqiang Wang, Shangli Cai, Yong Song, Liming Cao, Jianchun Duan
Published 2022-06-01

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer

by Teng Li, Han Wang, Jiachen Xu, Chengcheng Li, Yudong Zhang, Guoqiang Wang, Yutao Liu, Shangli Cai, Wenfeng Fang, Junling Li, Zhijie Wang
Published 2021-08-01

Circulating cell-free DNA for cancer early detection

by Qiang Gao, Qiang Zeng, Zhijie Wang, Chengcheng Li, Yu Xu, Peng Cui, Xin Zhu, Huafei Lu, Guoqiang Wang, Shangli Cai, Jie Wang, Jia Fan
Published 2022-07-01

Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan‐cancer analysis

by Dong Shen, Junling Zhang, Kai Yuan, Jing Zhao, Zhengyi Zhao, Longgang Cui, Yuzi Zhang, Guoqiang Wang, Shangli Cai, Yuezong Bai, Wei Li, Xiang Huang
Published 2021-08-01

Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitors

by Sujun Han, Yu Xu, Dong Chen, Feiya Yang, Mingshuai Wang, Qiaoxia Zhou, Guoqiang Wang, Leo Li, Chunwei Xu, Wenxian Wang, Shangli Cai, Nianzeng Xing
Published 2024-01-01

Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma

by Guangxian Mao, Dongyong Yang, Bin Liu, Yu Zhang, Sijia Ma, Shang Dai, Guoqiang Wang, Wenxiang Tang, Huafei Lu, Shangli Cai, Jialiang Zhu, Huaping Yang
Published 2023-07-01

Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squa...

by Yiting Sun, Jianchun Duan, Wenfeng Fang, Zhijie Wang, Xinyang Du, Xin Wang, Chengcheng Li, Shangli Cai, Jie Zhao, Sini Li, Li Zhang, Hua Bai, Jie Wang
Published 2021-10-01

TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma

by Wenjing Xiao, Nan Du, Taoyuan Huang, Jinan Guo, Xingkui Mo, Tao Yuan, Yong Chen, Ting Ye, Chunwei Xu, Wenxian Wang, Guoqiang Wang, Shangli Cai, Jing Chen
Published 2018-06-01

A prognostic signature based on adenosine metabolism related genes for ovarian cancer

by Weifeng Liang, Chao Zhou, Jingshu Wang, Jing Zhao, Fang Liu, Guoqiang Wang, Chunwei Xu, Yuzi Zhang, Wenxian Wang, Shangli Cai, Yusheng Han, Lei Chang, Peihai Zhang
Published 2022-11-01

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer

by Jian Xiao, Wenyun Li, Yan Huang, Mengli Huang, Shanshan Li, Xiaohui Zhai, Jing Zhao, Chan Gao, Wenzhuan Xie, Hao Qin, Shangli Cai, Yuezong Bai, Ping Lan, Yifeng Zou
Published 2021-03-01

bITH, a blood-based metric of intratumor heterogeneity, is associated with clinical response to immune checkpoint blockade in non-small cell lung cancerResearch in context

by Yun Fan, Yang Liu, Liuchun Wang, Yiran Cai, Wen Cao, Wenjie Sun, Xiao Zou, Bing Li, Zhou Zhang, Shangli Cai, Shannon Chuai, Yusheng Han, Xiaojie Pan, Dingzhi Huang
Published 2023-05-01

T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis

by Zhongqi Fan, Yutao Liu, Chengcheng Li, Yanfang Jiang, Nanya Wang, Mingda Wang, Chao Li, Yongkang Diao, Wei Qiu, Xin Zhu, Guoqiang Wang, Shangli Cai, Tian Yang, Guoyue Lv
Published 2024-01-01

The prognostic significance and clinical relevance of stem cell characteristic in bladder cancer

by Xia Chen, Yuanyuan Yin, Yuming He, Fanqi Meng, Jing Zhao, Fang Liu, Yu Xu, Guoqiang Wang, Xin Zhu, Sijia Ma, Huafei Lu, Shangli Cai, Yanping Song, Junyong Dai
Published 2024-02-01

Association between DNA damage repair gene somatic mutations and immune‐related gene expression in ovarian cancer

by Wenjuan Tian, Boer Shan, Yuzi Zhang, Yulan Ren, Shanhui Liang, Jing Zhao, Zhengyi Zhao, Guoqiang Wang, Xiaochen Zhao, Dongxian Peng, Rui Bi, Shangli Cai, Yuezong Bai, Huaying Wang
Published 2020-03-01

The rational application of liquid biopsy based on next‐generation sequencing in advanced non‐small cell lung cancer

by Chenglong Zhao, Jianghua Li, Yongchang Zhang, Rui Han, Yubo Wang, Li Li, Yimin Zhang, Mengxiao Zhu, Jie Zheng, Haiwei Du, Chen Hu, Chengzhi Zhou, Nong Yang, Shangli Cai, Yong He
Published 2023-03-01

A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma

by Jiachen Xu, Zhenlin Yang, Wenchuan Xie, Rui Wan, Chengcheng Li, Kailun Fei, Boyang Sun, Xu Yang, Ping Chen, Fanqi Meng, Guoqiang Wang, Jing Zhao, Yusheng Han, Shangli Cai, Jie Wang, Zhijie Wang
Published 2023-05-01